Platform Technology Partners Matinas Bio Pharma Holdings, Inc. Transaction History
Platform Technology Partners
- $243 Million
- Q4 2023
A detailed history of Platform Technology Partners transactions in Matinas Bio Pharma Holdings, Inc. stock. As of the latest transaction made, Platform Technology Partners holds 156,250 shares of MTNB stock, worth $25,000. This represents 0.01% of its overall portfolio holdings.
Number of Shares
156,250
Previous 162,410
3.79%
Holding current value
$25,000
Previous $21,000
61.9%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding MTNB
# of Institutions
43Shares Held
25.8MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA9.32MShares$1.49 Million0.0% of portfolio
-
Sargent Investment Group, LLC3.61MShares$577,6800.22% of portfolio
-
Black Rock Inc. New York, NY2.48MShares$397,1840.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.14MShares$341,6730.0% of portfolio
-
Arkadios Wealth Advisors1.62MShares$259,8400.04% of portfolio
About Matinas BioPharma Holdings, Inc.
- Ticker MTNB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,864,992
- Market Cap $34.7M
- Description
- Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...